ATA193077A - Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze - Google Patents

Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze

Info

Publication number
ATA193077A
ATA193077A AT771930A AT193077A ATA193077A AT A193077 A ATA193077 A AT A193077A AT 771930 A AT771930 A AT 771930A AT 193077 A AT193077 A AT 193077A AT A193077 A ATA193077 A AT A193077A
Authority
AT
Austria
Prior art keywords
salts
preparation
new
acetohydroxamic acids
acids
Prior art date
Application number
AT771930A
Other languages
English (en)
Other versions
AT356078B (de
Inventor
Lowis Lofon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of ATA193077A publication Critical patent/ATA193077A/de
Application granted granted Critical
Publication of AT356078B publication Critical patent/AT356078B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64Acyl halides
    • C07C57/72Acyl halides containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/56Radicals substituted by sulfur atoms
AT193077A 1976-03-23 1977-03-21 Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze AT356078B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB11710/76A GB1574822A (en) 1976-03-23 1976-03-23 Acetohydroxamic acid derivatives and pharmaceutical compositions thereof
GB629877 1977-02-15

Publications (2)

Publication Number Publication Date
ATA193077A true ATA193077A (de) 1979-09-15
AT356078B AT356078B (de) 1980-04-10

Family

ID=26240593

Family Applications (5)

Application Number Title Priority Date Filing Date
AT193077A AT356078B (de) 1976-03-23 1977-03-21 Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze
AT839978A AT358556B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung neuer aralkylsul- finyl-acetohydroxamsaeuren und deren salzen
AT0840078A AT362793B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung neuer ureido-acetohydroxamsaeuren und deren metallsalzen
AT839878A AT361932B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung von neuen piperazin-1 -yl-acethydroxamsaeuren und deren salzen
AT0501480A AT374191B (de) 1976-03-23 1980-10-09 Verfahren zur herstellung von neuen substituierten acethydroxamsaeuren und deren salzen

Family Applications After (4)

Application Number Title Priority Date Filing Date
AT839978A AT358556B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung neuer aralkylsul- finyl-acetohydroxamsaeuren und deren salzen
AT0840078A AT362793B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung neuer ureido-acetohydroxamsaeuren und deren metallsalzen
AT839878A AT361932B (de) 1976-03-23 1978-11-24 Verfahren zur herstellung von neuen piperazin-1 -yl-acethydroxamsaeuren und deren salzen
AT0501480A AT374191B (de) 1976-03-23 1980-10-09 Verfahren zur herstellung von neuen substituierten acethydroxamsaeuren und deren salzen

Country Status (25)

Country Link
US (7) US4122186A (de)
JP (1) JPS52144601A (de)
AT (5) AT356078B (de)
AU (1) AU516473B2 (de)
BE (1) BE852738A (de)
CA (2) CA1120928A (de)
CH (1) CH620894A5 (de)
CS (1) CS200511B2 (de)
DD (1) DD129645A5 (de)
DE (1) DE2711451A1 (de)
DK (1) DK171197B1 (de)
ES (1) ES457105A1 (de)
FI (1) FI62821C (de)
FR (4) FR2345430A1 (de)
GB (1) GB1574822A (de)
IE (1) IE44721B1 (de)
IL (1) IL51705A (de)
LU (1) LU76989A1 (de)
NL (1) NL188801C (de)
NO (4) NO144420C (de)
NZ (1) NZ183616A (de)
PH (1) PH16271A (de)
PT (1) PT66300B (de)
SE (4) SE432420B (de)
SU (1) SU689617A3 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
US4405357A (en) 1980-06-02 1983-09-20 Fmc Corporation Herbicidal 3-isoxazolidinones and hydroxamic acids
FR2502617B1 (de) * 1981-03-25 1984-04-27 Lafon Labor
FR2528041A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
JPS59222454A (ja) * 1983-05-31 1984-12-14 Ajinomoto Co Inc アミノ酸の製造方法
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
FR2584666B1 (fr) * 1985-07-10 1989-06-16 Champion Spark Plug Europ Bras moteur pour balai d'essuie-glace avec capuchon coulissant
FR2585699B1 (fr) * 1985-07-31 1988-03-11 Lafon Labor Derive d'acide acetohydroxamique, procede de preparation et utilisation en therapeutique
US5036157A (en) * 1986-03-11 1991-07-30 Burroughs Wellcome Co. Aryl derivatives
FR2601673B2 (fr) * 1986-07-21 1989-06-02 Lafon Labor Derives de l'acetamide et medicaments qui en contiennent
US4983567A (en) * 1987-03-16 1991-01-08 Biomeasure, Inc. Immunomodulators and methods of making same
ES2011588A6 (es) * 1989-05-29 1990-01-16 Vinas Lab Procedimiento para la preparacion de un nuevo derivado fenilacetico.
JPH0359402U (de) * 1989-10-13 1991-06-12
CA2028530A1 (en) * 1989-11-21 1991-05-22 Christian Hubschwerlen Substituted pyrimidobenzimidazole derivatives
US5283248A (en) * 1989-11-21 1994-02-01 Hoffmann-La Roche Inc. Amino substituted pyrimido[1,6-2]benzimidazoles
US5378701A (en) * 1991-12-27 1995-01-03 Kyowa Hakko Kogyo Tricyclic compounds
US6060477A (en) * 1995-06-07 2000-05-09 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
ATE263554T1 (de) * 1997-02-27 2004-04-15 Wyeth Corp N-hydroxy-2-(alkyl, aryl oder heteroaryl sulfanyl,sulfinyl oder sulfonyl)-3-substituierte alkyl-, aryl- oder heteroarylamide als matrixmetalloproteinaseinhibitoren
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6187924B1 (en) * 1997-11-12 2001-02-13 Darwin Discovery, Ltd. Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
PE20001566A1 (es) 1999-03-26 2001-02-05 Ucb Sa Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
US6686502B1 (en) 1999-03-26 2004-02-03 Ucb S.A. Compounds and methods for treatment of asthma, allergy and inflammatory disorders
GB9911071D0 (en) * 1999-05-12 1999-07-14 Darwin Discovery Ltd Hydroxamic and carboxylic acid derivatives
WO2003048114A2 (en) * 2001-12-04 2003-06-12 De Novo Pharmaceuticals Limited Bacterial enzyme inhibitors
DE10320453A1 (de) * 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Bioisostere von Actinonin
EP1644323B1 (de) * 2003-07-07 2015-03-18 Georgetown University Histondeacetylaseinhibitoren und verfahren zu deren anwendung
US7842835B2 (en) * 2003-07-07 2010-11-30 Georgetown University Histone deacetylase inhibitors and methods of use thereof
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
WO2007134169A2 (en) * 2006-05-10 2007-11-22 Nuada, Llc Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
US20090264384A1 (en) * 2004-11-01 2009-10-22 Nuada, Inc. Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
WO2007113644A2 (en) * 2006-04-05 2007-10-11 Orchid Research Laboratories Limited New hdac inhibitors
EP2041088B1 (de) 2006-06-28 2014-01-08 Amgen Inc. Inhibitoren des glycintransporters 1
CA2663569A1 (en) * 2006-09-28 2008-04-03 Merck & Co., Inc. Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexes
SI2343286T1 (sl) * 2006-10-28 2015-05-29 Methylgene Inc. Derivati dibenzo(b,f)(1,4) oksazepina kot inhibitorji histonske deacetilaze
WO2008094592A1 (en) * 2007-02-01 2008-08-07 Panthera Biopharna, Llc Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
FR2957492B1 (fr) 2010-03-18 2013-08-16 Rhodia Operations Nouvelles utilisations de composes de type esteramide
CN101982459A (zh) * 2010-10-21 2011-03-02 山东华尔康生物技术有限公司 乙酰氧肟酸的制备工艺
GB201509663D0 (en) * 2015-06-03 2015-07-15 Johnson Matthey Plc Benzo(h)quinoline ligands and complexes thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2862020A (en) * 1958-11-25 Derivatives of a-amino-p-hydroxy
US2279560A (en) * 1940-05-08 1942-04-14 Du Pont Viscous hydrocarbon oil
US2397508A (en) * 1943-05-29 1946-04-02 Standard Oil Co Hydroxamic acids
GB894119A (en) * 1959-11-02 1962-04-18 Ici Ltd Pivalic acid derivative
US3275643A (en) * 1963-07-19 1966-09-27 Irwin I Lubowe Allantoin-pantothenate compounds
US3634509A (en) * 1966-06-08 1972-01-11 Shell Oil Co 2 6-dinitroanilinoacetamides
NL6715600A (de) * 1966-12-02 1968-06-04
US3927092A (en) * 1968-06-24 1975-12-16 Merck & Co Inc Amides of 2-{8 halophenoxy (or halophenylthio){9 -alkanoic acids
DE1805548A1 (de) * 1968-10-26 1970-10-08 Agfa Gevaert Ag Benzimidazol-Derivate und ihre photographische Verwendung
FR2036953A1 (en) * 1969-04-23 1970-12-31 Pluripharm Diphenylhydantoin derivs
US4092430A (en) * 1970-09-09 1978-05-30 Ciba-Geigy Corporation Antiphlogistic phenylacetohydroxamic acid compositions
US3728380A (en) * 1971-05-17 1973-04-17 Morton Norwich Products Inc P-chlorobenzamidoacetohydroxamic acid
US3839580A (en) * 1972-08-14 1974-10-01 Morton Norwich Products Inc 2-p-(nitrobenzamido)acetohydroxamic for treating urinary tract infections
SE7411007L (de) * 1973-10-10 1975-04-11 Ciba Geigy Ag
JPS51102636A (en) * 1974-04-03 1976-09-10 Fuji Photo Film Co Ltd Karaashashingazo no keiseihoho
FR2285859A1 (fr) * 1974-09-30 1976-04-23 Lafon Labor Phenylsulfinyl-amidines et derives
CH593954A5 (de) * 1975-07-21 1977-12-30 Ciba Geigy Ag
US4029812A (en) * 1976-02-18 1977-06-14 The Dow Chemical Company Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides

Also Published As

Publication number Publication date
US4225617A (en) 1980-09-30
NO146431C (no) 1982-09-29
FR2453148B1 (de) 1983-12-02
US4151300A (en) 1979-04-24
ATA839978A (de) 1980-02-15
NO144420B (no) 1981-05-18
NO152972B (no) 1985-09-16
IL51705A (en) 1982-09-30
PT66300B (pt) 1978-08-10
DE2711451C2 (de) 1990-05-10
ATA840078A (de) 1980-11-15
SE456992B (sv) 1988-11-21
NO803338L (no) 1977-09-26
AT356078B (de) 1980-04-10
NO803336L (no) 1977-09-26
NO152972C (no) 1985-12-27
NL7703168A (nl) 1977-09-27
AU2334477A (en) 1978-09-21
DD129645A5 (de) 1978-02-01
DK171197B1 (da) 1996-07-22
ATA839878A (de) 1980-09-15
NO145881B (no) 1982-03-08
NO145881C (no) 1982-06-16
JPS628424B2 (de) 1987-02-23
NO144420C (no) 1981-08-26
US4183951A (en) 1980-01-15
AT358556B (de) 1980-09-25
IE44721B1 (en) 1982-03-10
AT361932B (de) 1981-04-10
GB1574822A (en) 1980-09-10
FI62821B (fi) 1982-11-30
FR2453158A1 (fr) 1980-10-31
JPS52144601A (en) 1977-12-02
FR2345430B1 (de) 1982-07-23
LU76989A1 (de) 1977-07-18
IL51705A0 (en) 1977-05-31
SE452155B (sv) 1987-11-16
DE2711451A1 (de) 1977-10-06
NO803337L (no) 1977-09-26
US4122186A (en) 1978-10-24
NO771006L (no) 1977-09-26
ATA501480A (de) 1983-08-15
SE8302171L (sv) 1983-04-19
US4152458A (en) 1979-05-01
PH16271A (en) 1983-08-25
PT66300A (fr) 1977-04-01
ES457105A1 (es) 1978-10-16
AT362793B (de) 1981-06-10
NL188801C (nl) 1992-10-01
CS200511B2 (en) 1980-09-15
FR2453133B1 (de) 1984-04-06
SU689617A3 (ru) 1979-09-30
CH620894A5 (de) 1980-12-31
FR2345430A1 (fr) 1977-10-21
NZ183616A (en) 1979-03-28
AU516473B2 (en) 1981-06-04
CA1130301A (en) 1982-08-24
FR2453148A1 (fr) 1980-10-31
FR2453158B1 (de) 1982-08-06
SE8302171D0 (sv) 1983-04-19
IE44721L (en) 1977-09-23
SE7703263L (sv) 1977-09-24
SE8302173D0 (sv) 1983-04-19
FI62821C (fi) 1983-03-10
SE8302172D0 (sv) 1983-04-19
US4209524A (en) 1980-06-24
SE8302173L (sv) 1983-04-19
SE458605B (sv) 1989-04-17
FR2453133A1 (fr) 1980-10-31
CA1120928A (en) 1982-03-30
DK126677A (da) 1977-09-24
NO146431B (no) 1982-06-21
SE432420B (sv) 1984-04-02
BE852738A (fr) 1977-09-22
US4209523A (en) 1980-06-24
AT374191B (de) 1984-03-26
SE8302172L (sv) 1983-04-19
FI770859A (de) 1977-09-24

Similar Documents

Publication Publication Date Title
ATA193077A (de) Verfahren zur herstellung neuer acetohydroxam- saeuren und deren salze
AT342610B (de) Verfahren zur herstellung neuer pyridazinderivate und deren saureadditionssalze
AT334881B (de) Verfahren zur herstellung neuer 1-phenoxy-2-hydroxy-3-aminopropane und deren saureadditionssalze
DD128562A5 (de) Verfahren zur herstellung von 7-methoxy-cephalosporinen und deren salzen
AT350737B (de) Verfahren zur herstellung neuer n-tetrahydro- furfuryl-noroxymorphone und deren saeure- additionssalzen
AT352135B (de) Verfahren zur herstellung neuer homophthalimide und ihrer salze
ATA498876A (de) Verfahren zur herstellung neuer 2-benzopyranon- derivate und ihrer salze
AT347960B (de) Verfahren zur herstellung neuer hydrazinopyri- dazinderivate und deren salzen
AT353259B (de) Verfahren zur herstellung neuer 3-nitropyrazol- derivate und deren salze
AT351031B (de) Verfahren zur herstellung neuer 3-aryl-2- piperazinyl-propionsaeuren und deren salze
AT350745B (de) Verfahren zur herstellung neuer 8- azaprostansaeurederivate und deren salzen
AT347923B (de) Verfahren zur herstellung neuer p-aminobenzoe- saeuren deren ester und salze
ATA867977A (de) Verfahren zur herstellung neuer l-substi- tuierter derivate von d-8-ergolin-i-ylessig- saeureamid und deren salze
AT341498B (de) Verfahren zur herstellung neuer 1-phenoxy-2-hydroxy-3-aminopropane und deren saureadditionssalze
AT341497B (de) Verfahren zur herstellung neuer 1-phenoxy-2-hydroxy-3-aminopropane und deren saureadditionssalze
AT358194B (de) Verfahren zur herstellung neuer n-tetrahydro- furfuryl-noroxymorphone und deren saeure- additionssalzen
ATA559977A (de) Verfahren zur herstellung neuer 5,9-beta- disubstituierter 2-tetrahydrofurfuryl-6,7- benzomorphane und deren saeureadditionssalze
ATA421177A (de) Verfahren zur herstellung neuer 2,6-di- subsitutierter 2-phenylimino-imidazolidine und deren saeureadditionssalze
ATA269779A (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
DD133236A1 (de) Verfahren zur herstellung von 2-phenyl-3-furyl-2-propensaeure und deren derivaten
AT343112B (de) Verfahren zur herstellung neuer imidazol-1-alkylcarbonsaurederivate und ihrer salze
ATA125378A (de) Verfahren zur herstellung von neuen aminoalkyl- phenoxyalkansaeuren und deren salzen
AT351543B (de) Verfahren zur herstellung neuer homophthalimide und ihrer salze
AT342611B (de) Verfahren zur herstellung neuer pyridazinderivate und deren saureadditionssalze
AT342773B (de) Verfahren zur herstellung neuer 9-alkylamino-erythromycine und ihrer salze

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties